Intuitive Surgical, Inc. (ISRG)
NASDAQ: ISRG · Real-Time Price · USD
548.55
+9.73 (1.81%)
At close: Nov 5, 2025, 4:00 PM EST
543.27
-5.28 (-0.96%)
Pre-market: Nov 6, 2025, 5:45 AM EST
Intuitive Surgical Market Cap
Intuitive Surgical has a market cap or net worth of $194.46 billion as of November 6, 2025. Its market cap has increased by 5.22% in one year.
Market Cap
194.46B
Enterprise Value
189.55B
1-Year Change
5.22%
Ranking
Category
Stock Price
$548.55
Market Cap Chart
Since June 16, 2000, Intuitive Surgical's market cap has increased from $314.50M to $194.46B, an increase of 61,731.10%. That is a compound annual growth rate of 28.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2025 | 194.46B | 4.60% |
| Dec 31, 2024 | 185.91B | 56.52% |
| Dec 29, 2023 | 118.77B | 26.67% |
| Dec 30, 2022 | 93.77B | -26.94% |
| Dec 31, 2021 | 128.36B | 33.46% |
| Dec 31, 2020 | 96.17B | 40.76% |
| Dec 31, 2019 | 68.32B | 24.92% |
| Dec 31, 2018 | 54.69B | 33.75% |
| Dec 29, 2017 | 40.89B | 66.41% |
| Dec 30, 2016 | 24.57B | 20.41% |
| Dec 31, 2015 | 20.41B | 6.43% |
| Dec 31, 2014 | 19.18B | 31.16% |
| Dec 31, 2013 | 14.62B | -25.02% |
| Dec 31, 2012 | 19.50B | 8.00% |
| Dec 30, 2011 | 18.05B | 78.27% |
| Dec 31, 2010 | 10.13B | -12.60% |
| Dec 31, 2009 | 11.59B | 133.30% |
| Dec 31, 2008 | 4.97B | -59.75% |
| Dec 31, 2007 | 12.34B | 248.28% |
| Dec 29, 2006 | 3.54B | -14.82% |
| Dec 30, 2005 | 4.16B | 205.79% |
| Dec 31, 2004 | 1.36B | 147.12% |
| Dec 31, 2003 | 550.50M | 144.12% |
| Dec 31, 2002 | 225.50M | -37.90% |
| Dec 31, 2001 | 363.10M | 19.72% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |